Cargando…
TGF-β1-induced bone marrow mesenchymal stem cells (BMSCs) migration via histone demethylase KDM6B mediated inhibition of methylation marker H3K27me3
Mesenchymal stem cells (MSCs) are widely used in clinical research and therapy. Since the number of MSCs migration is extremely crucial at the lesion site, exploring the mechanisms to enhance the migration of MSCs is necessary. Therefore, this study focused on the epigenetic mechanisms in MSCs migra...
Autores principales: | He, Qiting, Shi, Jie, Liu, Wei, Zhao, Wei, Wang, Zihao, Liu, Kaiwen, Zhao, Dawang, Wang, Shaoyi, Guo, Yongyuan, Cheng, Lei, Gao, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334584/ https://www.ncbi.nlm.nih.gov/pubmed/35902563 http://dx.doi.org/10.1038/s41420-022-01132-z |
Ejemplares similares
-
Epigenetic regulation of TGF-β-induced EMT by JMJD3/KDM6B histone H3K27 demethylase
por: Lee, Su-Hyun, et al.
Publicado: (2021) -
Metformin directly targets the H3K27me3 demethylase KDM6A/UTX
por: Cuyàs, Elisabet, et al.
Publicado: (2018) -
The Histone H3K27me3 Demethylases KDM6A/B Resist Anoikis and Transcriptionally Regulate Stemness-Related Genes
por: Shait Mohammed, Mohammed Razeeth, et al.
Publicado: (2022) -
Histone Demethylases as Counterbalance to H3K27me3 Silencing in Plants
por: Crevillén, Pedro
Publicado: (2020) -
Histone H3K36me2 demethylase KDM2A promotes bladder cancer progression through epigenetically silencing RARRES3
por: Lu, Bing, et al.
Publicado: (2022)